24Business
-
ROSEN, A LEADING LAW FIRM FOR INVESTORS’ RIGHTS, is urging investors of Cassava Sciences, Inc.
New York, New York–(Newsfile Corp. – January 3, 2025) – WHY: The Rosen Law Firm, a global investor rights law…
Read More » -
CFO of Pagaya Technologies sells shares for more than $212,000 Investing.com
In a recent transaction filing with the Securities and Exchange Commission, Evangelos Perros, chief financial officer of Pagaya (NASDAQ:) Technologies…
Read More » -
The chief development officer of Pagaya Technologies is selling $214,823 worth of shares to Investing.com
In a recent transaction filing with the Securities and Exchange Commission, Rosen Tami, chief development officer of Pagaya (NASDAQ:) Technologies…
Read More » -
Biden honors Vietnam War veterans and Nashville police with presidential medals Reuters
Author: Gabriella Borter (Reuters) – U.S. President Joe Biden on Friday honored seven veterans of the Korean and Vietnam wars…
Read More » -
Affirm Holdings CFO Robert O’Hare is selling $407K worth of shares via Investing.com
These transactions were conducted under a predetermined Rule 10b5-1 trading plan, which allows insiders to set a predetermined plan to…
Read More » -
SVP of Puma Biotechnology sells shares for $27,208 via Investing.com
Douglas M. Hunt, senior vice president of regulatory affairs at Puma Biotechnology, Inc. (NASDAQ:), recently sold 8,633 shares of the…
Read More » -
Evercommerce President Matthew Feierstein Sells $270,630 worth of stock By Investing.com
Matthew David Feierstein, President of EverCommerce Inc. (NASDAQ:EVCM), recently made a number of stock transactions, according to a filing with…
Read More » -
Puma Biotechnology Chief Commercial Officer Sells $29,742 worth of stock By Investing.com
In a recent filing with the Securities and Exchange Commission, Puma Biotechnology, Inc. (NASDAQ: ), a profitable biotech company with…
Read More » -
CFO Puma Biotechnology sells $32,232 worth of shares to Investing.com
Maximo F. Nougues, Chief Financial Officer of the company Puma Biotechnology, Inc. (NASDAQ:), a profitable biotechnology company currently valued at…
Read More » -
Lemonade’s insurance director is selling $1.12M worth of shares to Investing.com
John Sheldon Peters, director of insurance at Lemonade, Inc. (NYSE:LMND), recently sold $1,120,849 worth of stock, according to its most…
Read More »